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Aim: In this study, we explore the potential of ECG-gated
18F-FDG PET to assess LV systolic and diastolic function in a well-
stablished rat model of type 2 diabetes.
Introduction: Left ventricular (LV) diastolic dysfunction,
defined as a disruption of the normal filling pattern of the ventri-
cle but normal systolic function, is one of the early signs of cardiac
involvement in diabetic patients.
Methods: List-mode gated 18F-FDG PET imaging was performed
on a rat model of type 2 diabetes (ZDF fa/fa) (n = 6) and ZL control
rats (n = 6) at age of 13 weeks 15–30 min after tracer-administration
(37 MBq) via tail vein under hyperinsulinemic-euglycemic clamp
using a dedicated small animal PET system (Siemens Inveon)
with ECG signal recording for 20 min. List-mode data were
sorted and reconstructed into tomographic images of 16 frames
per cardiac cycle. PET images were resized to match human-
scale pixels. Left ventricular functional parameters were calcu-
lated using standard clinical software program (Heart Function
View).
Results: Hyperinsulinemic-euglycemic clamp and post mortem
tissue analysis demonstrated the development of diabetes in
the ZDF rats and of significant myocardial hypertrophy in ZDF
rats at age of 13 weeks (994 ± 78 mg vs. 871 ± 44 mg in ZDF
rats vs. ZL controls, p < 0.01, respectively). The PET images anal-
ysis showed a mild but significant decrease of LV PFR in the
ZDF rats (10.4 ± 0.5 vs. 11.8 ± 0.4 EDV/s in ZDF rats vs. ZL con-
trols, p < 0.001, respectively), whereas no significantly differences
concerning LVEF and cardiac output (CO) could be detected
between model and control rats (LVEF: 60.0 ± 4.5 vs. 63.7 ± 4.1%,
p = 0.25 and CO: 90917 ± 14015 vs. 85208 ± 17511 l/min, p = 0.90,
respectively).
Conclusion: In a rat model of type 2 diabetes, we demonstrated
the ability of ECG-gated-18F-FDG PET together with a clinical
ventricular edge detection software to assess reliable LV systolic
and diastolic parameters and to detect the presence of a diastolic
dysfunction in the diabetic rats.
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Aim: Analysis of frequency of use of DS/OTC among patients
with arterial hypertension as well as factors determining its use and
patients’ knowledge about possible interactions with conventional
medication.
Introduction: Dietary supplements (DS) and over-the-counter
drugs (OTC) are frequently advertised as a natural treatment of
many disorders. DS/OTC can interfere with biotherapeutic action of
prescribed medication and this is of particular concern in patients
with cardiovascular disease, many of whom are on long term treat-
ment.
Methods: The study was conducted in the Outpatient Hyper-
tensive Clinic in the Tertiary Cardiac Center. Self-prepared
questionnaire was administered among 151 hypertensive patients
(58% females, age range 18–80 years). Regular DS/OTC use was
defined as taking them at least 3 times per week.
Results: In the examined population regular use of DS/OTC
was declared by 67% subjects. The most commonly, regularly used
substances were minerals and microelements (60.4%), vitamins
(48.5%), analgesics (18.8%), drugs increasing the immunity (18.8%),
relieving the gastrointestinal symptoms (18.8%) and omega acids
(18.8%). There were no differences in the frequency of DS/OTC
use in relation to number of antihypertensive drugs, educational
level, age and income. Women are more frequent regular users of
DS/OTC than men (n = 65 vs. n = 36, p = 0.03). Only 38% of responders
always consulted the use of DS/OTC with a doctor. The majority
of responders (52%) is not aware of possible influence of DS/OTC
on antihypertensive medication or blood pressure control. Cost of
DS/OTC in 23% of responders is equal or higher than cost of pre-
scribed drugs.
Conclusion: Two thirds of hypertensive patients are regularly
using DS/OTC. Half of them are not aware of possible inter-
actions with antihypertensive therapy and influence of blood
pressure control. The perception that nonprescription therapies
are unnecessary to report during medication history taking should
be changed. DS/OTC are the important position in the responders
budget.
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